Okay, I just read it. I have two comments: Auth
Post# of 148281
Author states:
Quote:
I find the idea of searching the world for jurisdictions (Canada, Philippines, Brazil) that will allow CytoDyn to sell its massive leronlimab inventory to be repugnant.
Trying to sell a drug that can prevent the worst aspects of Covid is repugnant? I find the author utterly repugnant.
In the comments below, one person accuses the author of not listening to the conference call:
Quote:
tank1967 Today, 8:21 AM
This was written before the conference call. . . .
And, guess what, the author admits that he did not listen to it:
Quote:
Out of Ignorance Today, 8:57 AM Author's Reply @tank1967
Thank you for reading and for your penetrating comment. You are correct that I did not listen to the conference call. Did I miss something?
Yes, posting a negative article about a company immediately before market open, the day immediately after an after-market conference call, without listening to the conference call is a hit piece.